ORIGINAL RESEARCH
Accepted on 02 Jun 2025
Рrospective multicenter study of treatment efficacy, safety, and quality of life in a large cohort of patients with inborn errors of immunity receiving subcutaneous immunoglobulin
doi 10.3389/fimmu.2025.1598491
- 201 views